Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Glasses that see seizures coming: new wearable aims to predict epilepsy attacks

NCT ID NCT07139457

Symptom relief Sponsor: Oman Ministry of Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a pair of smart glasses called NEXA that can read brain signals through dry electrodes. The glasses aim to predict epileptic seizures in real time and alert the wearer with vibrations, lights, or sounds. Researchers will test the device on 47 adults with epilepsy to see if it can detect seizures with at least 95% accuracy in everyday settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wearable seizure prediction and alert glasses (NEXA glasses)
What this could lead to
If successful, these glasses could give people with epilepsy a reliable early warning before a seizure, improving safety and quality of life.
What could go wrong
This is an early-stage study with only 47 participants in Oman. The device is not yet approved and may not work as well in broader, real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 47 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (≥18 years) with a confirmed epilepsy diagnosis by a neurologist or epilepsy specialist. * History of active seizures within the last year, under stable treatment (medications, VNS, diet, or surgery) for at least 3 months. * Capacity to provide informed consent (or via legal representative if cognitively impaired). * Willingness to participate and sign consent. * Residents of Oman attending Khoula Hospital or affiliated clinics. * Stable general health without acute or severe comorbidities. * Ability and willingness to attend study visits and follow protocols. Exclusion Criteria: * Seizures from non-epileptic causes (e.g., psychogenic, metabolic, tumors). * Under 18 years of age. * Severe cognitive impairment preventing consent or protocol adherence. * Pregnant or planning pregnancy during the study. * Severe uncontrolled medical conditions (e.g., heart disease, cancer). * History of non-compliance with epilepsy treatment or follow-ups. * Severe psychiatric disorders affecting participation or safety. * History of substance abuse interfering with study adherence. * Known allergies or hypersensitivity to study medications or procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epilepsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epilepsy focal epilepsy visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Epilepsy Epileptic seizures Focal epilepsy

Contacts and locations

Locations

  • Khoula Hospital

    Muscat, Oman

More trials for these conditions

Other studies related to the condition(s) this trial covers.